Updates are available Correction dated 2025-01-31
Click to view Correction: https://doi.org/10.1038/s41386-025-02056-9
-
Authors
Wong, Dean F. https://orcid.org/0000-0001-9343-8367
Chand, Ganesh B.
Caito, Nicole
Eramo, Anna
Grattan, Vincent T.
Hixon, Mark S.
Nicol, Ginger https://orcid.org/0000-0001-5823-6129
Lessie, Erin
Prensky, Zachary
Kuwabara, Hiroto
Tian, Lucy
Valenta, Ines
Schindler, Thomas H.
Gründer, Gerhard
Vaino, Andrew R. https://orcid.org/0000-0002-4159-0778
-
Funding
Funding for this research was provided by:
LB Pharmaceuticals Inc.
LB Pharma, Paid Consultant
- License Information
-
More Information
Article History
Received: 4 February 2024
Revised: 15 July 2024
Accepted: 26 July 2024
First Online: 16 October 2024
Change Date: 31 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41386-025-02056-9
Competing interests
: VTG and MSH are consultants to, and shareholders of, LB Pharmaceuticals. AE, ZP, and ARV are employees and shareholders of LB Pharmaceuticals. DFW has WUSTL contracts with Eisai, Anavex, LB Pharma, Roche, Intracellular Technologies and is a paid consultant to Engrail Therapeutics and he and his CNAMI lab are supported by NIH (NIMH, NIDA, NIA, NIAAA) and the McDonnell Center for Systems Neuroscience at Washington University. GN has WUSTL contracts with COMPASS pathways, Usona Institute and Alkermes, Inc.; she has served as a paid consultant for Carelon, Novartis and Alkermes, Inc.; she and her staff in the Healthy Mind Lab are supported by research funding from the NIMH, the Health Resources and Services Administration (HRSA), the Patient Centered Outcomes Research Institute (PCORI); the Sidney R. Baer Jr. Foundation and the Barnes Jewish Hospital Foundation; the Institute for Clinical Translational Sciences, the Taylor Family Institute for Innovative Psychiatric Research, the Mallinckrodt Institute of Radiology and the McDonnell Center for Systems Neuroscience at Washington University. Gerhard Gründer is a paid consultant to LB Pharmaceuticals. GBC, NC, EL, HK, LT, IV, THS declare no conflict of interest.
